About Roche
What Roche is building
Technologies used at Roche
AWS
Docker
Python
Java
Ruby
C++Funding rounds
Total Funding
Last funding round type
Company type
Roche news and updates
Roche launched high-throughput SARS-CoV-2 antigen test for the diagnosis of SARS-CoV-2 infections on Dec 1st 20'.
Roche launched a high-throughput SARS-CoV-2 antigen test for the diagnosis of SARS-CoV-2 infections, in December 2020.
Dec 28, 2022 | digitaljournal.comASUS partnered with Roche on Dec 16th 22'.
ASUS today announced a strategic partnership with world-leading biotech company Roche to build precision medicine solutions for the burgeoning field of personalized healthcare.
Dec 15, 2022 | gadget-time.comRoche launches BRAF inhibitor Zelboraf
Novartis' Tafinlar won FDA approval after Roche launched its own BRAF inhibitor Zelboraf, but the Novartis med and its combo partner are bringing in more sales.
Dec 11, 2022 | fiercepharma.comRoche will hire Brad Moore as president and CEO on Jan 1st 23'.
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023.
Dec 8, 2022 | tissuepathology.comRoche is developing digital pathology applications on Oct 1st 21'.
In October 2021, A collaboration between Roche and PathAI to develop digital pathology applications based on artificial intelligence was announced.
Dec 7, 2022 | aimagazine.comReplimune Group partnered with Roche on Dec 7th 22'.
Replimune Group ( NASDAQ: REPL ), a biotech focused on cancer immunotherapies, announced a collaboration with Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) on Wednesday to study combination therapies for colorectal cancer (CRC) and hepatocellular carcinoma (HCC).
Dec 7, 2022 | seekingalpha.comBill Anderson left Roche as boss on Dec 19th 22'.
Bill Anderson, the former boss of Roche's Genentech unit, would quit at the end of the year "to pursue opportunities outside of Roche", with a successor due to be named by March 2023, Roche said in a statement.
Nov 30, 2022 | yahoo.comTechx partners with Roche
Dr. Syed Azizur Rab, CEO Greenstar Social Marketing said at the occasion, “Techx is very proud to partner with Roche in implementing the first of its kind community outreach program where women in catchment areas will receive free screening services and referred for further assessment”.
Nov 28, 2022 | techx.pkRoche launched KAPA Target Enrichment portfolio and the KAPA HyperExome on May 1st 20'.
In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.
Nov 16, 2022 | yahoo.comRoche is developing version of gantenerumab
Alzheimer's Association’s Chief Science Officer Maria Carrillo, Ph.D., also flagged an updated version of gantenerumab that Roche is developing that uses “brain shuttle technology” to move the drug across the blood-brain barrier and boost concentrations of the active ingredient in the brain.
Nov 14, 2022 | fiercebiotech.comRoche is developing AI pathology technology on Oct 1st 22'.
The firm and the pharmaceutical and diagnostics business Roche announced a strategic partnership in October to develop and market AI pathology technology through Roche’s uPath enterprise software, a lab workflow platform.
Nov 6, 2022 | pinkribbonlove.comHookipa Pharma Inc. partnered with Roche on Oct 20th 22'.
HOOKIPA Pharma Inc., a company developing a new class of immunotherapies based on its proprietary arenavirus platform, announced today a strategic collaboration and license agreement with Roche to develop HB-700 for KRAS-mutated cancers and a second undisclosed novel arenaviral immunotherapy.
Oct 19, 2022 | pharmafocusasia.comInxMed partners with Roche
InxMed has entered into a global clinical collaboration with Roche to evaluate IN10018 in combination with Cobi before.
Oct 17, 2022 | prnewswire.comRoche launched Anti-PRAME Rabbit Monoclonal Primary Antibody to identify PRAME protein expression on Sep 17th 22'.
Roche recently announced the launch of Anti-PRAME (EPR 20330) Rabbit Monoclonal Primary Antibody to identify PRAME protein expression in tissue samples from patients with suspected melanoma.
Oct 16, 2022 | medtechasia.inRoche is developing LungFlag technology on Jul 1st 22'.
In July 2022, Roche announced a partnership with EarlySign to develop and commercialize their LungFlag technology.
Oct 12, 2022 | medgadget.comRoche launched Prame Antibody on Oct 11th 22'.
Roche, meanwhile, today launched the Prame (EPR20330) Antibody, which runs on the company’s IHC/ISH instruments, and is intended for use specifically on tissue samples from patients with suspected melanoma.
Oct 10, 2022 | evaluate.comRoche launched CE-IVD automated digital pathology algorithms, uPath HER2 Dual ISH image analysis and uPath HER 2 image analysis on Jan 1st 21'.
For instance, In January 2021, Roche, a healthcare company, launched the CE-IVD automated digital pathology algorithms, uPath HER2 Dual ISH image analysis and uPath HER 2 (4B5) image analysis for the diagnosis of breast cancer.
Oct 9, 2022 | panews.comRoche launches remote patient monitoring service for heart diseases
Roche and Medixine launch a new remote patient monitoring service for heart diseases.
Oct 4, 2022 | medixine.comRoche hires Huang as Vice President of Global Business Development for EKF Diagnostics
Before joining Roche, Mr. Huang was Vice President of Global Business Development for EKF Diagnostics, a UK point-of-care diagnostics company, where he led corporate strategy and solidified strategic partnerships.
Oct 3, 2022 | prnewswire.comSchobel left Roche as group medical director on Oct 3rd 22'.
Dr. Schobel joins Vico from Roche where he was clinical science leader for the tominersen development program for Huntington's disease LEIDEN, Netherlands, Oct. 3, 2022 /PRNewswire/ -- Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced the appointment of Scott Schobel, MD as chief medical officer.
Oct 2, 2022 | biospace.comRoche launched SARS-CoV-2 Rapid Antibody Test 2.0 on Oct 3rd 22'.
ROTKREUZ, Switzerland, Oct. 3, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the SARS-CoV-2 Rapid Antibody Test 2.0 in markets accepting the CE Mark.
Oct 2, 2022 | prnewswire.co.ukRoche launched Hemlibra on Jan 1st 17'.
In 2017, Roche launched Hemlibra, the first easily injectable treatment that helps hemophilia A patients prevent bleeding episodes.
Sep 23, 2022 | fool.comRoche recognized as one of the most sustainable companies in the pharmaceuticals industry
In recognizing its endeavor to pursue a long-term perspective in all Vbprofiles do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year.
Sep 8, 2022 | topionetworks.comRoche acquired Ariosa on Dec 1st 14'.
Ariosa was acquired by Roche in Dec 2014.
Sep 8, 2022 | tracxn.comRoche acquired Good Therapeutics, Inc. for $250M on Sep 7th 22'.
Roche acquired privately held Good Therapeutics and its immuno-oncology platforms for $250 million, plus future milestone payments, on Wednesday.
Sep 7, 2022 | biospace.comRoche is developing Good's lead program
The deal makes Roche responsible for developing and commercializing Good's lead program, which seeks to make oncology drugs that target PD-1 proteins more effective, such as Keytruda or Opdivo.
Sep 6, 2022 | medcitynews.comPhoreMost Ltd partners with Roche
PhoreMost Ltd., a UK-based biopharmaceutical company, has entered into a multi-project target discovery collaboration with Roche, a leading biotechnology company.
Sep 5, 2022 | contractpharma.comRoche partners with Novo Nordisk Education Foundation
Roche Diabetes Care is very proud to partner with NNEF, who has been dedicated towards this cause.
Aug 25, 2022 | rochediabetes.comRoche launches Digital LightCyclerⓇ System
Roche has announced the launch of the Digital LightCyclerⓇ System, its first digital polymerase chain reaction (PCR) system.
Aug 24, 2022 | pf-media.co.ukRoche launched two new next-generation sequencing panels for cancer diagnosis on Nov 1st 19'.
For instance, in November 2019, Roche launched two new next-generation sequencing (NGS) panels for cancer diagnosis.
Aug 22, 2022 | bdtonline.comJemincare partnered with Roche on Aug 18th 22'.
Shanghai, China-based Jemincare today announced entering into an exclusive worldwide license agreement with Swiss pharma giant Roche (ROG: SIX) and its US subsidiary Genentech, for the development and commercialization of its androgen receptor degrader, JMKX002992.
Aug 17, 2022 | thepharmaletter.comDisc Medicine, Inc. partnered with Roche on Jan 1st 21'.
Disc entered a licensing agreement with Roche in 2021 to develop and commercialize bitopertin for porphyria.
Aug 16, 2022 | porphyrianews.comRoche launched CoaguChek Pro II system on Nov 1st 15'.
In November 2015, Roche announced the launch of the CoaguChek Pro II system in countries accepting the CE Mark.
Aug 16, 2022 | medgadget.comRoche hired Barnett on Jan 1st 00'.
Barnett joined Roche Diagnostics in 2000.
Jun 29, 2022 | instaprodukt.comSteve Gardner leaves Roche as CEO
PrecisionLife CEO, Dr Steve Gardner, joins guest speakers from Roche and Merck at the International Conference on Precision Regenerative Medicine, hosted by the Taiwan Ministry of Health and Welfare.
Jun 29, 2022 | precisionlife.comRoche hires Schwan as chief executive officer
Schwan, who is also chief executive officer of Swiss pharmaceutical giant Roche Holding AG, had come under repeated criticism that his dual mandates don’t leave him enough time to fulfill his duties at the lender.
Mar 21, 2022 | swissinfo.chSingulargenomics partnered with Roche on Feb 28th 22'.
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a collaboration with Roche to enable its KAPA Library Preparation Kits, including the KAPA EvoPlus and KAPA HyperPrep Kits, to work seamlessly with the G4 sequencing platform.
Feb 28, 2022 | globenewswire.comNewspakistan partners with Roche
CEO Greenstar Social Marketing Dr. Syed Azizur Rab held: “Newspakistan is very proud to partner with Roche in implementing the first of its kind community outreach program where women in catchment areas will receive free screening services and referred for further assessment”.
Feb 11, 2022 | newspakistan.tvAquinnah Pharmaceuticals partnered with Roche on Feb 15th 22'.
In other related ALS news, Aquinnah Pharmaceuticals announced it signed a deal with Roche to advance experimental treatments for the disease.
Jan 1, 2022 | biospace.comRoche launched software for digital pathologies, uPath on Jan 1st 19'.
January 2019: Roche introduced its new software for digital pathologies, uPath.
Jan 1, 2022 | yahoo.comRoche is developing pralsetinib for RET-altered cancers on Jul 1st 20'.
In July 2020, Roche ( OTCQX:RHHBY ) partnered with Blueprint Medicines ( BPMC +0.8% ) to develop and commercialize pralsetinib for RET-altered cancers.
Jan 1, 2022 | seekingalpha.comRoche launches Accu-Chek Instant system, a new "connected" blood glucose monitoring system
Roche has announced the launch of the new Accu-Chek Instant system, a new "connected" blood glucose monitoring (BGM) system, which supports and enables Roche’s approach of integrated Personalised Diabetes Management (iPDM).
Jan 1, 2022 | med-technews.comEpizyme, Inc. partners with Roche
Epizyme has entered into a clinical supply agreement with Roche for the bispecific cohort of the Company’s Phase 1b/2 basket study.
Jan 1, 2022 | biospace.comRoche closes offices in West and South
Most of the closures were in the Northeast and Midwest, but some schools were starting to close in the West and South, Roche said.
Jan 1, 2022 | lapps.orgRoche is developing app to help people with multiple sclerosis better manage symptoms
Global pharmaceutical company, Roche, is testing a new app to help people with multiple sclerosis (MS) better manage their symptoms.
Jan 1, 2022 | plymouth.ac.ukRoche is developing Floodlight MS
Roche is teaming up with the University of Plymouth in the U.K. to help develop Floodlight MS, the company’s app to monitor multiple sclerosis (MS).
Jan 1, 2022 | multiplesclerosisnewstoday.comFinbb partners with Roche
FINBB announces a research agreement with Roche.
Jan 1, 2022 | finbb.fiRoche has issues with patent infringement charges
When it comes to patent infringement charges, however, the case between Roche and Cipla has unquestionably set the standard, and this verdict will serve as a precedent for future instances.
Jan 1, 2022 | lawtimesjournal.inRoche receives award 2021 India Competitive Strategy Leadership Award
Based on its recent analysis of the Indian in vitro diagnostics (IVD) market, Frost & Sullivan recognizes Roche Diagnostics India with the 2021 India Competitive Strategy Leadership Award for its well-executed country strategies, effective market penetration, and innovative offerings.
Jan 1, 2022 | frost.comGlytec partnered with Roche on Jan 1st 22'.
The collaboration with Roche Diagnostics USA could bring some long overdue recognition to Waltham, MA-based Glytec and underscore the need for Glytec's technology in the hospital setting.
Jan 1, 2022 | mddionline.comRoche launched Accu-Chek Instant system on Feb 1st 21'.
– In-depth Analysis Pre & Post COVID-19 Market Outbreak Impact Analysis For instance, Roche introduced its new Accu-Chek Instant system in Feb 2021.
Jan 1, 2022 | digitaljournal.comRoche launched data from prasinezumab clinical programme on Mar 19th 22'.
At the AD/PD 2022 International Conference on Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), Roche presented new data from its prasinezumab clinical programme during a 19 March session on advances in PD and lewy body dementia (LBD) drug development.
Jan 1, 2022 | clinicaltrialsarena.comRoche hired Cris as Director of HR on Jan 1st 02'.
In 2002, Cris joined Roche as Director of HR at the Diagnostics US headquarters in Indianapolis, Indiana (U.S.) and four years later, she was appointed North America Region Head of HR.
Jan 1, 2022 | bigmarker.comRoche launched Accu-check on Jan 1st 18'.
For instance, in January 2018, Roche introduced its new product, "Accu-check," which enables a blood glucose monitoring system that presents a unique shred with a large easy-edge dosing region.
Jan 1, 2022 | yahoo.comRoche launched digital platform in Thailand on Dec 1st 20'.
In December 2020, Roche launched a digital platform in Thailand to personalize diabetes management.
Jan 1, 2022 | prnewswire.comRoche will develop next generation of immunotherapy treatments on Apr 6th 22'.
Roche (ROG.S) said on Wednesday a late stage trial for its tiragolumab drug to treat small cell lung cancer has failed to reach its targets, dealing a blow to the Swiss company's effort to develop the next generation of immunotherapy treatments.
Jan 1, 2022 | mtv.com.lbRoche launches III SKYSCRAPER-02 study
Roche announced that the phase III SKYSCRAPER-02 study, evaluating the investigational anti-TIGIT immunotherapy tiragolumab plus Tecentriq (atezolizumab) and chemotherapy (carboplatin and etoposide) as an initial (first-line) treatment for people with extensive-stage small cell lung cancer (ES-SCLC), did not meet its co-primary endpoint of progression-free survival.
Jan 1, 2022 | clival.comRoche launches OCREVUS data
Roche announced new OCREVUS (ocrelizumab) data that show its benefit on disease progression and cognitive outcomes in primary progressive multiple sclerosis (PPMS) and secondary progressive MS (SPMS).
Jan 1, 2022 | pharmajournalist.comRoche partners with Bristolmyerslaw
Roche has partnered with Bristol Myers for the development of digital pathology AI that helps detect and assess clinical trial assays.
Jan 1, 2022 | digitaljournal.comRoche launches updated interim data from the RAINBOWFISH study in pre-symptomatic babies
Roche also announced updated interim data from the RAINBOWFISH study in pre-symptomatic babies with SMA under two months of age.
Jan 1, 2022 | globenewswire.comRoche is developing small molecule drugs targeting gram-negative bacteria on Nov 1st 21'.
In November 2021, Venatorx entered a licensing and research agreement with Roche to develop small molecule drugs targeting gram-negative bacteria.
Jan 1, 2022 | fiercebiotech.comRoche launched data from the JEWELFISH study on Mar 14th 22'.
Roche recently released data from the JEWELFISH study, which evaluated the effect of switching to Evrysdi in SMA patients with treatment history.
Jan 1, 2022 | koreabiomed.comRoche partners with Causaly Inc.
Roche is partnering with Causaly to build a unified and systematic approach to drive better project and portfolio level decisions.
Jan 1, 2022 | causaly.comCerveau Technologies, Inc. partners with Roche
Further, Cerveau Technologies also announced research collaboration with Roche on the use of Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status and progression of neurofibrillary tangles (NFTs) in the brain.
Jan 1, 2022 | biospace.comRoche launched CoaguChek Vantus system, a self-testing gadget with wireless INR reporting capabilities on Apr 1st 18'.
• In April 2018, Roche, a Swiss global healthcare business, launched the CoaguChek Vantus system, a self-testing gadget with wireless INR reporting capabilities.
Jan 1, 2022 | globenewswire.comRegeneron Pharmaceuticals Inc. partners with Roche
Regeneron is collaborating with Roche, which is primarily responsible for the development and distribution of the treatment outside the United States.
Jan 1, 2022 | saltwire.comRoche is developing antibodies that target alpha-synuclein
Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies.
Jan 1, 2022 | defenseworld.netRoche had issues with violating the field restrictions of the 2003 licensing agreement on Jan 1st 10'.
That didn’t sit well with Meso, which in 2010 sued Roche for violating the field restrictions of the 2003 licensing agreement.
Jan 1, 2022 | fiercebiotech.comRoche launches drug to blockbuster medicine Tecentriq
Roche added the new drug to its blockbuster medicine Tecentriq in patients with a form of lung cancer.
Jan 1, 2022 | investors.comRoche launched DISCOVERY Green HRP kit on Mar 1st 21'.
For instance, in March 2021, Roche launched the DISCOVERY Green HRP kit to detect and profile biomarkers and cell populations in tissue-based research.
Jan 1, 2022 | digitaljournal.comRoche launches immunotherapy drug Tecentriq
For example, Swiss drugmaker Roche announced a drug cocktail including its immunotherapy drug Tecentriq failed a late-stage trial in women with ovarian cancer when it did not increase survival without the disease progressing.
Jan 1, 2022 | commetric.comRoche launches Phase 3 SKYSCRAPER-01 study of investigational anti-TIGIT immunotherapy tiragolumab plus Tecentriq
Roche announced that the Phase 3 SKYSCRAPER-01 study of its investigational anti-TIGIT immunotherapy tiragolumab plus Tecentriq (atezolizumab) did not meet the co-primary endpoint of progression-free survival (PFS).
Jan 1, 2022 | ns-healthcare.comRoche launched Global Access Program on Jan 1st 14'.
Roche launched its Global Access Program in 2014 to support the Joint United Nations Programme on HIV/AIDS (UNAIDS) 2020 targets to address the HIV/AIDS epidemic, since which time its scope has expanded to include solutions for other diseases including TB, hepatitis B and C and human papillomavirus (HPV).
Jan 1, 2022 | europeanpharmaceuticalreview.comRoche partners with Globalfund
Through its Global Access Program, Roche will work with the Global Fund to "strengthen diagnostic capacity and pandemic preparedness in low- and middle-income countries fighting against HIV and tuberculosis," it said in a statement.
Jan 1, 2022 | 360dx.comBryan retired from Roche as associate minister on May 14th 19'.
Bryan, who retired from Roche and is an associate minister at New Hope Christian Church, said it was Janice’s idea to write the book and they began three years ago.
Jan 1, 2022 | youarecurrent.comRoche launches three-year data of study evaluating Evrysdi
May 09, 2022 - Roche recently announced new three-year data of its study evaluating Evrysdi (risdiplam) in infants with symptomatic Type 1 spinal muscular atrophy (SMA).
Jan 1, 2022 | pharmanewsintel.comRoche launched Perjeta on Jan 1st 15'.
In 2015, Roche launched Perjeta, a breast cancer drug in the UK for use in women with HER2-positive breast cancer before surgery.
Jan 1, 2022 | digitaljournal.comKalivir partnered with Roche on May 23rd 22'.
KaliVir Immunotherapeutics, Inc. today announced a collaboration and global exclusive licensing agreement with Roche for the discovery, development and commercialization of novel oncolytic vaccinia viruses derived from KaliVir's oncolytic immunotherapy VET TM platform.
Jan 1, 2022 | prnewswire.comIgen International, Inc. sold assets to Roche on Jan 1st 03'.
In 2003, Roche acquired a license from Igen to operate in the field of “human patient diagnostics.”
Jan 1, 2022 | jdsupra.comRoche launches Accu-Fine
Mumbai, India, 9 May 2022: Roche Diabetes Care India (RDC India) today announced the launch of Accu-Fine, quality pen needles to make the process of insulin delivery smoother and virtually painless for people with diabetes.
Jan 1, 2022 | rochediabetes.comRoche launches Lightmix Modular Virus test kits
Roche and subsidiary TIB Molbiol unveiled their Lightmix Modular Virus test kits on Wednesday — three unique test kits that can help track the spread of monkeypox.
Jan 1, 2022 | endpts.comHarpoon Therapeutics partnered with Roche on May 1st 22'.
In May, Harpoon signed a supply agreement with Roche to get access to the Swiss drugmaker's medicine atezolizumab (Tecentriq) for use in Harpoon's planned clinical trials to evaluate HPN328 in combination with atezolizumab to treat of patients with SCLC.
Jan 1, 2022 | seekingalpha.comRoche launched AVENIO Edge System on Dec 1st 21'.
In December 2021, Roche launched the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine.
Jan 1, 2022 | benzinga.comPsychoGenics Inc. partners with Roche
PsychoGenics Inc. has also partnered with Roche, Blue Oak and Karuna Therapeutics to identify potential novel drug candidates for the treatment of severe neuropsychiatric disorders.
Jan 1, 2022 | psychogenics.comRoche launches three PCR-based test kits
Swiss pharma Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) has already introduced three PCR-based test kits to detect the virus.
Jan 1, 2022 | seekingalpha.comRoche identified as competitor of Zolgensma
The new approval will help Roche better compete with Novartis and its gene therapy Zolgensma, which is often administered soon after birth, and with Biogen’s drug Spinraza.
Jan 1, 2022 | biopharmadive.comReparerx partnered with Roche on Jun 1st 22'.
Repare Therapeutics Inc. (Nasdaq: RPTX ) 17% HIGHER; entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib (also known as RP-3500), a potent and selective oral small molecule inhibitor of ATR (Ataxia-Telangiectasia and Rad3-related protein kinase) for the treatment of tumors with specific synthetic-lethal genomic alterations including those in the ATM gene (Ataxia-Telangiectasia mutated kinase).
Jan 1, 2022 | streetinsider.comRoche will develop ATR inhibitor camonsertib on Jun 8th 22'.
Roche and Repare Therapeutics on Wednesday announced a global license agreement to develop and market Repare's ATR inhibitor camonsertib as a treatment for tumors with synthetic-lethal genomic alterations.
Jan 1, 2022 | precisiononcologynews.comRoche is developing factor VIII gene transfer treatment for hemophilia A in a phase I/II study
Roche is developing a factor VIII gene transfer treatment for hemophilia A in a phase I/II study.
Jan 1, 2022 | nasdaq.comRoche launches Accu-Chek Guide
For instance, healthcare giant Roche has launched Accu-Chek Guide, a glucose monitoring system that facilitates on-board mode testing through a mobile application.
Jan 1, 2022 | seamaty.comRoche launched CE mark availability of Roche v-TAC on Jan 1st 20'.
For instance, in 2020, Swiss multinational healthcare company, Roche, introduced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that provides clinicians with results for arterial blood gas values from patients with respiratory or metabolic abnormalities through the same, less invasive venous puncture with the utilization of a digital algorithm.
Jan 1, 2022 | globenewswire.comDecentriq partnered with Roche on May 3rd 22'.
Decentriq recently closed a 15 Mio USD series A financing round and publicly announced a collaboration with Roche.
Jan 1, 2022 | swiss.techNordic Bioscience partners with Roche
Nordic Bioscience has announced the strengthening of its ongoing collaboration with Roche for the development of proprietary biomarkers involved in tissue breakdown and build-up.
Jan 1, 2022 | pharmatimes.comRoche launched HPV self-sampling solution on Jun 15th 22'.
Roche last week announced the launch of an HPV “self-sampling solution” that allows patients to collect their own samples at healthcare facilities for use on the Basel-based company’s Cobas HPV diagnostic platform.
Jan 1, 2022 | linksbridge.comRoche receives award two awards at 6th CSR Health Impact Awards 2022
Roche Diabetes Care India has been granted two awards at the 6th CSR Health Impact Awards 2022 conferred by the Integrated Health & Wellbeing Council for their work in the space of improving access to care through education and awareness campaigns.
Jan 1, 2022 | rochediabetes.comRoche launches VENTANA DP 600 slide scanner generation
Biotechnology company Roche has announced the launch of its next-generation VENTANA DP 600 slide scanner (CE-IVD marked).
Jan 1, 2022 | voicebrook.comRoche partners with Bicycle Therapeutics
Roche Group member Genentech has expanded the exclusive strategic partnership agreement with Bicycle Therapeutics by exercising its second option to commence a new programme.
Jan 1, 2022 | pharmaceutical-technology.comRoche launches NT Pro BNP test
In the process, Roche has introduced the NT Pro BNP test, a spot test to rule out heart failure.
Jan 1, 2022 | medicaldialogues.inRoche launched Ventana PD-L1 Assay on Mar 1st 19'.
Similarly, in March 2019, Roche launched the Ventana PD-L1 (SP142) Assay in Europe as the first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq.
Jan 1, 2022 | myfutureclub.comRoche launches Elecsys HCV Duo immunoassay
Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys® HCV Duo immunoassay in countries that accept the CE Mark.
Jan 1, 2022 | globenewswire.comRoche will develop novel AAV gene therapy vectors on Jul 26th 22'.
Pittsburgh-based Avista Therapeutics announced Tuesday a partnership with Roche to develop novel AAV gene therapy vectors for the eyes.
Jan 1, 2022 | pennbizreport.comRoche hires Thomas Schinecker as chief executive officer
Roche has announced the appointment of Thomas Schinecker as its new chief executive officer (CEO), while the company’s former CEO, Severin Schwan, moves into his role as chairman of the board.
Jan 1, 2022 | pmlive.comRoche launched AcceleRET Lung study on Jul 14th 22'.
Accordingly, in early 2020, Roche launched the global randomized, controlled Phase III study, AcceleRET Lung, which was requested by the FDA.
Jan 1, 2022 | friendsofcancerresearch.orgRoche is developing several allogeneic CAR-T programs
Under the agreement, Roche will receive from Poseida either exclusive rights or options to develop and commercialize several allogeneic CAR-T programs in Poseida's portfolio.
Jan 1, 2022 | benzinga.comRoche partnered with Sysmex Europe GmbH on Jan 1st 21'.
In January 2021, Roche announced a strategic partnership with Sysmex to utilize their respective IT platforms for improving customer experience with a longer-term ambition to use the IT systems and improve clinical decision making.
Jan 1, 2022 | globenewswire.comKiniksa partners with Roche
Kiniksa Pharmaceuticals has entered into a global license agreement with Roche and its subsidiary, Genentech, for the development and commercialisation of an investigational fully human monoclonal antibody, vixarelimab.
Jan 1, 2022 | pharmaceutical-business-review.comPoseida Therapeutics, Inc. partners with Roche
Poseida Therapeutics, Inc. announced it has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies.
Jan 1, 2022 | pharmajournalist.comElgersma partners with Roche
Elgersma is collaborating with the pharmaceutical company Roche on its own ASO treatment for Angelman syndrome.
Jan 1, 2022 | spectrumnews.orgRoche is developing allogeneic CAR-T therapies for hematologic malignancies
Poseida Therapeutics has announced a global strategic collaboration with Roche to develop allogeneic CAR-T therapies for hematologic malignancies.
Jan 1, 2022 | crisprmedicinenews.comRoche launches Elecsys IGRA SARS-CoV-2 test
Roche announced the launch of the Elecsys® IGRA SARS-CoV-2 test in countries that accept the CE Mark1.
Jan 1, 2022 | pharmafocusasia.comRoche launched two digital pathology image analysis algorithms image analysis and uPath HER2 Dual ISH image analysis) for precision patient diagnosis in breast cancer on Jan 1st 20'.
Roche launched two digital pathology image analysis algorithms (uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis) for precision patient diagnosis in breast cancer to help determine the best treatment strategy for each patient in January 2021.
Dec 6, 2021 | bdtonline.comRoche launched Personalized Healthcare Index on Jul 1st 20'.
This is in line when Roche launched the Personalized Healthcare Index for Asia- Pacific early last year and it was revealed that all health systems are on a trajectory towards delivering PHC, with some at the earliest stages while others are building the foundations or already making the transition.
Jun 30, 2021 | roche.com.myRoche invests into assets : manufacturing lines for consumables and 20 new manufacturing lines
On the company's fourth quarter earnings call in January, Schinecker said Roche had invested more than CHF 600 million ($664 million) to increase its supply chain capacities, adding 60 new manufacturing lines for consumables and 20 new manufacturing lines for reagents.
Jan 1, 2021 | genomeweb.comLineage Cell Therapeutics, Inc. will partner with Roche on Dec 1st 22'.
With its subsidiary, Cell Cure Neurosciences Ltd., Lineage signed an exclusive worldwide collaboration and license pact with Roche and its Genentech arm.
Jan 1, 2021 | bioworld.comRoche launched data on investigational CD20xCD3 T-cell engaging bispecific antibodies, mosunetuzumab and glofitamab on Jun 4th 21'.
Swiss pharma giant Roche (ROG: SIX) today announced new data on its investigational CD20xCD3 T-cell engaging bispecific antibodies, mosunetuzumab and glofitamab, and its first-in-class anti-CD79b antibody-drug conjugate, Polivy (polatuzumab vedotin), in non-Hodgkin lymphoma (NHL) that are being presented at the 2021 ASCO Annual Meeting.
Jan 1, 2021 | thepharmaletter.comRoche partnered with TIB Molbiol GmbH on Sep 1st 21'.
Roche has worked with TIB Molbiol for more then 20 years to quickly address biological threats.
Jan 1, 2021 | medicaldevice-network.comRoche launched VENTANA HER2 Dual ISH DNA Probe Cocktail assay for detecting the HER2 biomarker in gastric and breast cancer on May 1st 19'.
In May 2019, Cardinal Health had announced the launch of its RADIAL 360 portfolio in the U.S. With this there is increase product portfolio which provides a complete range of products for Trans Radial Approach (TRA) for interventional cardiology procedures In May 2019, Roche made an announcement to launch the VENTANA HER2 Dual ISH DNA Probe Cocktail assay for detecting the HER2 biomarker in gastric and breast cancer.
Jan 1, 2021 | stillwatercurrent.comEarlySign partnered with Roche on Sep 13th 21'.
Medial EarlySign (earlysign.com), a pioneering company developing AI-based clinical predictive analytics, announced today the signing of a definitive partnership agreement with Roche.
Jan 1, 2021 | prnewswire.comHarman International partnered with Roche on Sep 26th 19'.
HARMAN, a wholly-owned subsidiary of Samsung Electronics Co. Ltd., focused on connected technologies for automotive, consumer and enterprise markets, announced today that it has entered into a multi-year, global partnership with Roche to create a digital therapeutic platform for individuals with autism spectrum disorder (ASD).
Jan 1, 2020 | harman.comRoche partners with Mass
Roche, Basel, Switzerland, announced a partnership with Moderna Inc., Cambridge, Mass, to utilize the Elecsys Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials.
Jan 1, 2020 | microbiozindia.comNimble Therapeutics Inc. partners with Roche
Nimble Therapeutics Inc., of Madison, Wis., is partnering with Roche Diagnostics, a division of Basel, Switzerland-based Roche Holding AG, to discover and develop novel peptide-based compounds for SARS-CoV-2 in vitro diagnostics.
Jan 1, 2020 | bioworld.comRoche is developing healthcare supply chain management system
SAP, Roche and Tenthpin announced a collaboration to create a healthcare supply chain management system.
Jan 1, 2020 | safeoclock.comScenic Biotech partners with Roche
Scenic Biotech has entered into a multi-year strategic partnership with Roche unit Genentech in a bid to discover, develop and commercialise new drugs against genetic modifiers.
Jan 1, 2020 | pharmaceutical-technology.comRoche acquires Boehringer
Pharmaceutical firm Boehringer, which was acquired by the Switzerland-based Roche Group in the late 1990s, used to operate from several buildings in Tutzing, but operations moved from there in 2002.
Jan 1, 2020 | cdrecycler.comLokon Pharma AB partners with Roche
She adds, “Lokon Pharma AB is currently collaborating with Roche in studies evaluating LOAd703 combined with atezolizumab in patients with pancreatic cancer and malignant melanoma.
Jan 1, 2020 | mynewsdesk.comRoche launches PCR test to detect Severe Acute Respiratory Syndrome Coronavirus 2
Roche: One of the largest healthcare companies worldwide, among many initiatives, Roche has launched a PCR test to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, has been diligently and urgently working to bring a reliable immunoassay solution to the market.
Jan 1, 2020 | busup.comKaiku Health partners with Roche
Kaiku has also been working with Roche since 2019, with the companies extending the digital monitoring and management partnership (DPMM) in May this year to further develop the DPMM tools, in order to provide real-time symptom management, as well as improved patient support.
Mar 13, 2019 | pmlive.comRoche invested into Sarepta Therapeutics, Inc. in $1.15B cash and an equity investment on Dec 30th 19'.
Roche paid $750 million upfront and invested another $400 million in Sarepta Therapeutics to acquire ex-US rights to Sarepta's clinical-stage treatment for DMD.
Jan 1, 2019 | seekingalpha.comRoche partnered with Sarepta Therapeutics, Inc. on Dec 1st 19'.
In December 2019, Roche partnered with Sarepta to combine Roche’s global reach, commercial presence and regulatory expertise with Sarepta’s gene therapy candidate for Duchenne to accelerate access to SRP-9001 for patients outside the United States.
Jan 1, 2019 | cureduchenne.orgRoche identified as competitor of Novartis Pharmaceuticals Corporation on Jan 1st 19'.
Twin late-stage trials of Roche’s ophthalmology drug faricimab have hit the mark in “wet” age-related macular degeneration trial, as the company’s challenge to rivals from Novartis and Bayer strengthens.
Jan 1, 2019 | pharmaphorum.comRoche merged with Genentech on Jan 1st 09'.
Similarly, Dragonfly and Merck have announced a new business deal for about $700 million just a week after Roche and Genentech merger.
Jan 1, 2018 | mmjobserver.comRoche acquires Seragon Pharmaceuticals Inc. for $725M
Roche acquired Seragon the following year.
Jan 1, 2017 | medcitynews.comHorizon Discovery Group plc partnered with Roche on Dec 18th 17'.
Horizon Discovery Group plc announces that it has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry (IHC) assays.
Jan 1, 2017 | technologynetworks.comRoche launched CINtec Plus cervical ICC assay1 on Feb 24th 14'.
24th February 2014 Roche launched the CINtec Plus (p16/Ki67) cervical ICC assay1.
Feb 23, 2014 | bioconnexions.comRoche launched Elecsys Anti-Müllerian Hormone blood test on Sep 18th 14'.
Roche today announced the launch of the Elecsys Anti-Müllerian Hormone (AMH) blood test, the first fully-automated AMH test for assessing a woman’s ovarian reserve.
Jan 1, 2014 | obgyneditorial.comRoche decreased headcount by 100 on Oct 1st 13'.
In October, Roche announced plans to cut 100 jobs in diabetes and shift the business' diagnostics division to its Indianapolis headquarters while moving the glucose monitor unit to Germany.
Jan 1, 2013 | 3gbio.com.cn